andrographi
paniculata
burm
f
nee
acanthacea
paniculata
chuanxinlian
medicin
herb
use
mani
region
taiwan
mainland
china
india
treat
liver
disord
colic
pain
common
cold
respiratori
infect
andrographolid
deriv
wide
use
treat
respiratori
infect
china
india
decad
contain
diterpenoid
flavonoid
polyphenol
major
bioactiv
compon
andrographolid
major
diterpenoid
paniculata
make
dri
whole
plant
stem
leaf
extract
respect
also
use
wonder
drug
tradit
sidha
ayurved
system
medicin
well
tribal
medicin
india
multipl
clinic
applic
sinc
ancient
also
shown
effect
certain
cancer
effect
purg
plant
extract
exhibit
antityphoid
antifung
antihepatotox
antibiot
antimalari
antihepatit
antithrombogen
antiinflammatori
antisnak
venom
antipyret
properti
mention
besid
gener
use
immunostimul
andrographolid
test
differ
experiment
studi
human
anim
prove
andrographolid
safe
drug
harm
side
effect
object
find
new
bioactiv
molecul
treatment
swine
flu
method
present
studi
attempt
elucid
inhibit
potenti
andrographolid
deriv
along
associ
bind
mechan
virtual
screen
molecular
dock
simul
studi
result
find
reveal
structur
conform
chang
loop
secondari
sialic
acid
bind
site
residu
neuraminidas
andrographolid
identifi
highest
bing
energi
kcalmol
hydrogen
bond
interact
total
intermolecular
energi
kcalmol
bioactiv
valu
ki
nmoll
food
drug
admistraton
approv
drug
oseltamivir
zanamivir
shown
hydrogen
bond
interact
bind
energi
kcalmol
respect
higher
andrographolid
guanidin
group
bind
affin
hydrophil
natur
inhibitor
oh
group
identifi
dock
andrographolid
cid
neuraminidas
conclus
henc
andrographolid
potenti
inhibit
neuraminidas
activ
may
use
altern
medicin
therapi
swine
flu
posit
patient
potent
antivir
activ
potenti
new
mechan
action
andrographolid
may
warrant
evalu
possibl
therapi
influenza
swine
flu
sever
contagi
diseas
caus
viru
lead
respiratori
tract
infect
complic
bronchiti
pneumonia
human
world
health
organ
report
cumul
confirm
case
cumul
death
case
caus
oct
contain
two
surfac
glycoprotein
hemagglutinin
neuraminidas
hemagglutinin
facilit
influenza
viru
attach
host
cell
initi
infect
viral
rna
enter
cell
endocytosi
neuraminidas
cleav
linkag
sialic
acid
nacetylneuramin
adjac
sugar
residu
spread
infect
cell
amino
acid
sequenc
neuraminidas
code
rna
segment
polypeptid
chain
neuraminidas
compris
amino
acid
residu
inhibit
neuraminidas
use
prevent
could
serv
potenti
drug
target
due
develop
resist
mani
strain
food
drug
administr
approv
neuraminidas
inhibitor
drug
oseltamivir
zanamivir
moreov
due
sever
side
effect
like
nausea
vomit
abdomin
pain
headach
rash
sometim
allerg
reaction
includ
anaphylaxi
etc
call
new
inhibitor
influenza
viru
less
side
effect
amino
acid
sequenc
neuraminidas
ablor
genbank
known
threedimension
structur
avail
studi
therefor
construct
structur
homolog
model
thereaft
taken
interact
studi
andrographolid
utmost
import
structurebas
drug
design
reliabl
filter
put
hit
term
predict
bind
affin
base
insilico
gener
near
nativ
proteinligand
configur
andrographolid
deriv
use
studi
identifi
inhibitori
potenti
sever
receptorcentr
comput
methodolog
comput
model
andrographolid
deriv
potent
inhibitor
neuraminidas
protein
protein
sequenc
neuraminidas
strain
obtain
influenza
viru
resourc
offici
databas
influenza
viru
resourc
nation
center
biotechnolog
inform
protein
compris
amino
acid
sequenc
similar
search
blast
protein
data
bank
pdb
databas
give
similar
protein
ident
templat
pdb
id
select
molecular
model
good
resolut
perform
pairwis
align
refer
use
lalign
emboss
figur
homolog
model
protein
built
use
modweb
onlin
server
modweb
server
compar
protein
structur
model
depend
larg
scale
protein
structur
model
pipelin
modpip
function
structur
templat
use
build
model
modpip
pdb
id
sequencestructur
match
establish
use
multipl
variat
sequencesequ
profilesequ
sequenceprofil
profileprofil
align
method
signific
align
evalu
better
cover
least
amino
acid
residu
select
model
final
result
model
evalu
use
sever
model
assess
scheme
model
evalu
perform
procheck
produc
plot
analyz
overal
residuebyresidu
geometri
ramachandran
plot
provid
program
procheck
assur
good
confid
predict
protein
nevertheless
procheck
assur
reliabl
structur
protein
subject
avail
nih
mbi
laboratori
server
insilico
predict
bind
site
done
neuraminidas
use
castp
qsite
finder
compar
extens
literatur
search
best
activ
site
select
compar
predict
castp
algorithm
qsite
finder
bind
site
activ
site
surfac
structur
pocket
access
interior
caviti
inaccess
shape
alpha
complex
triangul
area
volum
solvent
molecular
access
surfac
pocket
caviti
protein
identifi
measur
castp
method
number
area
circumfer
mouth
open
pocket
solvent
molecular
access
surfac
determin
castp
ligand
bind
site
protein
predict
qsite
finder
bind
hydrophob
probe
protein
use
determin
bind
energi
probe
cluster
protein
probe
cluster
favour
bind
energi
arrang
order
pocket
surfac
protein
detect
pocket
finder
method
scan
probe
radiu
grid
resolut
cubic
diagon
ligand
along
protein
initi
dataset
andrographolid
analogu
collect
ncbi
pubchem
compound
databas
virtual
screen
basi
lipinski
rule
sever
differ
ring
system
repres
ligand
convert
pdb
coordin
file
use
openbabel
softwar
wwwopenbabelorg
ligand
prepar
ad
hydrogen
bond
neutral
charg
group
optim
ligand
subsequ
dock
use
compound
associ
vitro
bioactiv
valu
valu
report
nmoll
neuraminidas
strain
order
check
reliabl
geometri
obtain
compar
structur
paramet
andrographolid
theoret
experiment
valu
literatur
order
understand
bind
pattern
mechan
andrographolid
herbal
deriv
toward
inhibit
dock
herbal
compound
receptor
perform
use
ensur
protein
ligand
correct
form
dock
receptorgrid
file
gener
use
gridreceptor
gener
program
use
van
der
waal
scale
receptor
default
size
use
bound
enclos
box
ligand
dock
initi
use
standard
precis
method
refin
use
xtra
precis
lamarckian
genet
algorithm
standard
dock
protocol
ten
independ
dock
run
carri
ligand
result
cluster
accord
rmsd
criteria
best
ligand
select
basi
hbond
format
hydrophob
interact
minimum
bind
energi
obtain
dock
singl
best
conform
ligand
consid
analysi
atom
coordin
neuraminidas
influenza
viru
avail
pdb
henc
develop
protein
model
necessari
final
model
took
analysi
consist
amino
acid
residu
resolut
procheck
softwar
use
check
qualiti
model
protein
structur
ramachandran
plot
obtain
program
procheck
check
stereochem
qualiti
protein
structur
produc
number
postscript
plot
analyz
overal
residuebyresidu
geometri
assur
reliabl
model
protein
residu
allow
region
addit
allow
region
none
residu
disallow
region
gener
allow
region
figur
assess
deriv
profil
base
local
environ
residu
describ
statist
prefer
area
residu
buri
fraction
sidechain
area
cover
polar
atom
oxygen
nitrogen
local
secondari
structur
also
substanti
reliabl
threedimension
structur
activ
site
identifi
refer
studi
done
use
castp
qsite
finder
verifi
avail
literatur
tabl
combin
result
obtain
standard
dock
protocol
investig
effici
andrographolid
deriv
four
herbal
compound
imperatorin
andrographolid
epigallocatechin
arabinoxylan
angelica
archangelica
paniculata
green
tea
hyphomycet
mycelia
respect
figur
lig
dock
simul
andrographolid
deriv
homolog
model
perform
use
andrographolid
ligand
dock
defin
bind
site
top
configur
dock
taken
consider
valid
result
tabl
rmsd
valu
calcul
ten
accept
pose
configur
found
reveal
dock
configur
similar
bind
posit
orient
within
bind
site
similar
crystal
structur
best
dock
structur
configur
lowest
bind
score
compar
crystal
structur
shown
figur
dock
andrographolid
deriv
bind
site
perform
use
standard
dock
protocol
bind
mode
andrographolid
within
bind
site
repres
figur
figur
observ
molecul
well
fit
defin
bind
pocket
andrographolid
analogu
also
found
good
binder
bind
mode
andrographolid
deriv
show
hydrophob
interact
bind
mode
prove
hypothesi
andrographolid
deriv
bind
almost
hydrophob
interact
preorgan
shape
bind
rigid
structur
andrographolid
analogu
bind
pocket
dock
interact
analysi
carri
per
previou
studi
highli
pathogen
influenza
virus
spread
relentlessli
across
globe
sinc
infect
human
report
mortal
rate
influenza
viral
infect
still
major
health
concern
option
control
treatment
diseas
limit
recent
year
normal
mortal
associ
influenza
viru
circul
five
year
ago
also
hit
younger
peopl
highli
notici
variant
viru
appear
even
lethal
strain
influenza
viru
unexpect
mutat
year
year
therefor
import
get
annual
flu
vaccin
unfortunit
vaccin
immun
suppress
ie
suppress
immun
system
might
increas
risk
contract
flu
infecti
diseas
sinc
vaccin
bypass
natur
firstlin
defens
therefor
never
protect
typic
provid
inferior
immun
compar
bodi
would
receiv
natur
contract
recov
diseas
addit
flu
vaccin
particularli
ineffect
reduc
ill
mortal
flu
accord
us
center
diseas
control
prevent
flulik
ill
actual
caus
influenza
type
b
caus
virus
respiratori
viru
bocaviru
coronaviru
rhinoviru
etc
therefor
threat
new
pandem
requir
develop
new
therapeut
agent
dock
result
show
andrographolid
cid
best
among
four
herbal
compound
carboxyl
function
group
bind
activ
site
residu
along
neuraminidas
lowest
bind
energi
kcalmol
ie
high
bind
effeci
compound
includ
andrographolid
show
bind
loop
activ
site
neuraminidas
total
intermolecular
energi
found
kcalmol
inhibit
constant
ki
nmoll
studi
reveal
structur
conform
chang
loop
secondari
sialic
acid
bind
site
residu
neuraminidas
guanidin
group
bind
affin
hydrophil
natur
inhibitor
oh
group
identifi
dock
interestingli
andrographolid
found
fit
ligand
activ
site
residu
approv
drug
swine
flu
zanamivir
cid
oseltamivir
cid
zanamivir
found
interact
low
bing
affininti
kcalmol
compar
andrographolid
addit
oseltamivir
also
fail
fight
andrographolid
studi
prove
inform
might
use
design
futur
neuraminidas
inhibitor
rapidli
mutat
strain
